Menu
GWAS Study

Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.

Gallagher CS, Mäkinen N, Harris HR et al.

31649266 PubMed ID
GWAS Study Type
202580 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GC
Gallagher CS
MN
Mäkinen N
HH
Harris HR
RN
Rahmioglu N
UO
Uimari O
CJ
Cook JP
SN
Shigesi N
FT
Ferreira T
VD
Velez-Edwards DR
ET
Edwards TL
MS
Mortlock S
RZ
Ruhioglu Z
DF
Day F
BC
Becker CM
KV
Karhunen V
MH
Martikainen H
JM
Järvelin MR
CR
Cantor RM
RP
Ridker PM
TK
Terry KL
BJ
Buring JE
GS
Gordon SD
MS
Medland SE
MG
Montgomery GW
ND
Nyholt DR
HD
Hinds DA
TJ
Tung JY
PJ
Perry JRB
LP
Lind PA
PJ
Painter JN
MN
Martin NG
MA
Morris AP
CD
Chasman DI
MS
Missmer SA
ZK
Zondervan KT
MC
Morton CC
Chapter II

Abstract

Summary of the research findings

Uterine leiomyomata (UL) are the most common neoplasms of the female reproductive tract and primary cause for hysterectomy, leading to considerable morbidity and high economic burden. Here we conduct a GWAS meta-analysis in 35,474 cases and 267,505 female controls of European ancestry, identifying eight novel genome-wide significant (P < 5 × 10-8) loci, in addition to confirming 21 previously reported loci, including multiple independent signals at 10 loci. Phenotypic stratification of UL by heavy menstrual bleeding in 3409 cases and 199,171 female controls reveals genome-wide significant associations at three of the 29 UL loci: 5p15.33 (TERT), 5q35.2 (FGFR4) and 11q22.3 (ATM). Four loci identified in the meta-analysis are also associated with endometriosis risk; an epidemiological meta-analysis across 402,868 women suggests at least a doubling of risk for UL diagnosis among those with a history of endometriosis. These findings increase our understanding of genetic contribution and biology underlying UL development, and suggest overlapping genetic origins with endometriosis.

3,409 European ancestry cases, 199,171 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

202580
Total Participants
GWAS
Study Type
Yes
Replicated
15,068 European ancestry cases, 43,587 European ancestry controls
Replication Participants
European
Ancestry
Finland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.